233 related articles for article (PubMed ID: 26889125)
1. mp-MRI Prostate Characterised PIRADS 3 Lesions are Associated with a Low Risk of Clinically Significant Prostate Cancer - A Retrospective Review of 92 Biopsied PIRADS 3 Lesions.
Liddell H; Jyoti R; Haxhimolla HZ
Curr Urol; 2015 Jul; 8(2):96-100. PubMed ID: 26889125
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
3. In-gantry MRI guided prostate biopsy diagnosis of prostatitis and its relationship with PIRADS V.2 based score.
Jyoti R; Jina NH; Haxhimolla HZ
J Med Imaging Radiat Oncol; 2017 Apr; 61(2):212-215. PubMed ID: 27987276
[TBL] [Abstract][Full Text] [Related]
4. Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate.
Kuru TH; Roethke MC; Rieker P; Roth W; Fenchel M; Hohenfellner M; Schlemmer HP; Hadaschik BA
BJU Int; 2013 Dec; 112(8):1080-7. PubMed ID: 23937255
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility artifacts and PIRADS 3 lesions in prostatic MRI: how often is the dynamic contrast-enhance sequence necessary?
Antunes N; Vas D; Sebastia C; Salvador R; Ribal MJ; Nicolau C
Abdom Radiol (NY); 2021 Jul; 46(7):3401-3409. PubMed ID: 33683430
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the PI-RADSv2 classification in a cohort of patients who underwent a prostate fusion biopsy.].
Rodríguez Cabello MÁ; Sanz Migueláñez JL; Méndez Rubio S; Arias Fúnez F; Garrido Abad P; Carrillo Guivernau MJ; Velasco Ruíz M; González Gordaliza C; Platas Sancho A
Arch Esp Urol; 2020 Jan; 73(1):1-10. PubMed ID: 31950917
[TBL] [Abstract][Full Text] [Related]
7. Comparison of PIRADS 3 lesions with histopathological findings after MRI-fusion targeted biopsy of the prostate in a real world-setting.
Schlenker B; Apfelbeck M; Armbruster M; Chaloupka M; Stief CG; Clevert DA
Clin Hemorheol Microcirc; 2019; 71(2):165-170. PubMed ID: 30562897
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging radiomic features for recurrent prostate cancer following proton radiation therapy-A pilot study.
Bazargani S; Feibus AH; Elshafei A; Al-Toubat M; Gopireddy DR; Gautam S; Barwari S; Henderson R; Lall C; Balaji KC; Bandyk M
Urol Oncol; 2023 Mar; 41(3):145.e1-145.e5. PubMed ID: 36496342
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging of the prostate and targeted biopsy, Comparison of PIRADS and Gleason grading.
Bastian-Jordan M
J Med Imaging Radiat Oncol; 2018 Apr; 62(2):183-187. PubMed ID: 28990727
[TBL] [Abstract][Full Text] [Related]
10. Role of Multi-Parametric Magnetic Resonance Image and PIRADS Score in Patients with Prostate Cancer Eligible for Active Surveillance According PRIAS Criteria.
Almeida GL; Petralia G; Ferro M; Ribas CA; Detti S; Jereczek-Fossa BA; Matei DV; Coman I; De Cobelli O; Tagliabue E
Urol Int; 2016; 96(4):459-69. PubMed ID: 27045167
[TBL] [Abstract][Full Text] [Related]
11. Central zone lesions on magnetic resonance imaging: Should we be concerned?
Tan WP; Mazzone A; Shors S; Antoine N; Ekbal S; Khare N; McKiel C; Pessis D; Deane L
Urol Oncol; 2017 Jan; 35(1):31.e7-31.e12. PubMed ID: 27692837
[TBL] [Abstract][Full Text] [Related]
12. MRI-TRUS fusion biopsy of the prostate: Quality of image fusion in a clinical setting.
Schlenker B; Apfelbeck M; Buchner A; Stief C; Clevert DA
Clin Hemorheol Microcirc; 2018; 70(4):433-440. PubMed ID: 30347605
[TBL] [Abstract][Full Text] [Related]
13. "In-bore" MRI-guided Prostate Biopsy Using an Endorectal Nonmagnetic Device: A Prospective Study of 70 Consecutive Patients.
Schiavina R; Vagnoni V; D'Agostino D; Borghesi M; Salvaggio A; Giampaoli M; Pultrone CV; Saraceni G; Gaudiano C; Vigo M; Bianchi L; Dababneh H; La Manna G; Chessa F; Romagnoli D; Martorana G; Brunocilla E; Porreca A
Clin Genitourin Cancer; 2017 Jun; 15(3):417-427. PubMed ID: 28258961
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer detection using magnetic resonance imaging-transrectal ultrasound fusion biopsy: A retrospective cohort study.
Pratihar SK; Khanna A; Vasudeo V; Gupta R; Saurabh N; Kumar B; Ali M; Akotkar SS; Rawal SK; Singh A
Indian J Urol; 2023; 39(4):297-302. PubMed ID: 38077193
[TBL] [Abstract][Full Text] [Related]
15. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].
Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T
Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069
[TBL] [Abstract][Full Text] [Related]
16. Correlation of 3T multiparametric prostate MRI using prostate imaging reporting and data system (PIRADS) version 2 with biopsy as reference standard.
Mathur S; O'Malley ME; Ghai S; Jhaveri K; Sreeharsha B; Margolis M; Zhong L; Maan H; Toi A
Abdom Radiol (NY); 2019 Jan; 44(1):252-258. PubMed ID: 30032385
[TBL] [Abstract][Full Text] [Related]
17. Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: a retrospective cohort study.
Washino S; Kobayashi S; Okochi T; Kameda T; Konoshi T; Miyagawa T; Takayama T; Morita T
BMC Urol; 2018 May; 18(1):51. PubMed ID: 29843694
[TBL] [Abstract][Full Text] [Related]
18. Optimal Prostate Cancer Diagnostic Pathways for Men With Prostatomegaly in the MRI Era.
Gold SA; Goueli R; Mostardeiro TR; Carpinito GP; El-Eishy A; Mauck R; Woldu SL; Strand DW; Lotan Y; Roehrborn CG; Costa DN; Gahan JC
Urology; 2023 Sep; 179():95-100. PubMed ID: 37182648
[TBL] [Abstract][Full Text] [Related]
19. PROGNOSTIC SIGNIFICANCE OF MAGNETIC RESONANCE IMAGING IN PATIENTS WITH PROSTATE INTRAEPITHELIAL NEOPLASIA.
Мelnychuk MP
Wiad Lek; 2021; 74(1):35-38. PubMed ID: 33851583
[TBL] [Abstract][Full Text] [Related]
20. Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across Radiologists.
Sonn GA; Fan RE; Ghanouni P; Wang NN; Brooks JD; Loening AM; Daniel BL; To'o KJ; Thong AE; Leppert JT
Eur Urol Focus; 2019 Jul; 5(4):592-599. PubMed ID: 29226826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]